{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T21:55:29Z","timestamp":1787003729521,"version":"build-2736575974"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T00:00:00Z","timestamp":1764028800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T00:00:00Z","timestamp":1764028800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"German Research Council","award":["(BR 1704\/6-1, BR 1704\/6-3, BR 1704\/6-4, CH 117\/1-1, HO 5117\/2-1, HE 5998\/2-1, KL 2354\/3-1, RO 2270\/8-1 and BR 1704\/17-1)"],"award-info":[{"award-number":["(BR 1704\/6-1, BR 1704\/6-3, BR 1704\/6-4, CH 117\/1-1, HO 5117\/2-1, HE 5998\/2-1, KL 2354\/3-1, RO 2270\/8-1 and BR 1704\/17-1)"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Precis. Onc."],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    We evaluated the joint relationship of post-operative C-reactive protein (poCRP) and a tumor immune-cell-score (IS) with overall survival (OS) and CRC-specific survival (CSS) in 680 colorectal cancer (CRC) patients recruited in Germany. CRP was assessed post-surgery while IS was derived from CD3\u2009+\u2009\/CD8+ cell densities in tumor tissue. Patients were categorized into four\n                    <jats:bold>C<\/jats:bold>\n                    -\n                    <jats:bold>R<\/jats:bold>\n                    eactive protein-\n                    <jats:bold>I<\/jats:bold>\n                    mmune cell\n                    <jats:bold>S<\/jats:bold>\n                    core (CRIS) groups: CRIS-1 (CRP-low\/IS-high), CRIS-2 (CRP-low\/IS-low), CRIS-3 (CRP-high\/IS-high), and CRIS-4 (CRP-high\/IS-low). Associations of CRIS with survival were assessed using Cox regression, and quantified by hazard ratios with 95% confidence intervals (HR, 95%CI). Subgroup analysis by presence of non-metastatic disease and time of blood draw in relation to adjuvant chemotherapy were conducted. After a median follow-up of 9.6 (IQR, 4.6\u201314.6) years, 214 (31.5%) patients died, 140 (20.6%) from CRC. Patients in CRIS-4 category had worse prognosis compared to CRIS-1 category [HR\n                    <jats:sub>(95%CI)<\/jats:sub>\n                    : 2.01 (1.32\u20133.08) and 2.60 (1.57\u20134.32) for OS and CSS, respectively]. These associations were stronger for non-metastatic disease (OS\n                    <jats:sub>HR<\/jats:sub>\n                    \u2009=\u20092.45, CSS\n                    <jats:sub>HR<\/jats:sub>\n                    \u2009=\u20094.49), as well as for patients with blood collected after adjuvant chemotherapy (OS\n                    <jats:sub>HR<\/jats:sub>\n                    \u2009=\u20094.17, CSS\n                    <jats:sub>HR<\/jats:sub>\n                    \u2009=\u20096.62). Integrating post-operative systemic inflammation and tumor immune characteristics may improve prognostic stratification of patients receiving adjuvant chemotherapy for non-metastatic CRC.\n                  <\/jats:p>","DOI":"10.1038\/s41698-025-01192-1","type":"journal-article","created":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T16:15:42Z","timestamp":1764087342000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Predicting colorectal cancer survival by combined c-reactive protein and tumor immune score"],"prefix":"10.1038","volume":"9","author":[{"given":"Tafirenyika","family":"Gwenzi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Durgesh","family":"Wankhede","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanwei","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megha","family":"Bhardwaj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petra","family":"Schrotz-King","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie C.","family":"Anker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ben","family":"Sch\u00f6ttker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Hoffmeister","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hermann","family":"Brenner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,25]]},"reference":[{"key":"1192_CR1","first-page":"229","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray, F. et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 74, 229\u2013263 (2024).","journal-title":"CA Cancer J. Clin."},{"key":"1192_CR2","doi-asserted-by":"publisher","DOI":"10.1186\/s12957-021-02207-4","volume":"19","author":"I van den Berg","year":"2021","unstructured":"van den Berg, I., Coebergh van den Braak, R. R. J., van Vugt, J. L. A., Ijzermans, J. N. M. & Buettner, S. Actual survival after resection of primary colorectal cancer: results from a prospective multicenter study. World J. Surg. Oncol. 19, 96 (2021).","journal-title":"World J. Surg. Oncol."},{"key":"1192_CR3","first-page":"233","volume":"73","author":"RL Siegel","year":"2023","unstructured":"Siegel, R. L., Wagle, N. S., Cercek, A., Smith, R. A. & Jemal, A. Colorectal cancer statistics, 2023. CA Cancer J. Clin. 73, 233\u2013254 (2023).","journal-title":"CA Cancer J. Clin."},{"key":"1192_CR4","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1002\/ijc.29805","volume":"138","author":"N Turner","year":"2016","unstructured":"Turner, N. et al. Analysis of local chronic inflammatory cell infiltrate combined with systemic inflammation improves prognostication in stage II colon cancer independent of standard clinicopathologic criteria. Int J. Cancer 138, 671\u2013678 (2016).","journal-title":"Int J. Cancer"},{"key":"1192_CR5","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1038\/bjc.2016.17","volume":"114","author":"JH Park","year":"2016","unstructured":"Park, J. H. et al. Mismatch repair status in patients with primary operable colorectal cancer: associations with the local and systemic tumour environment. Br. J. Cancer 114, 562\u2013570 (2016).","journal-title":"Br. J. Cancer"},{"key":"1192_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinre.2023.102171","volume":"47","author":"SC Efil","year":"2023","unstructured":"Efil, S. C. et al. Prognostic and predictive value of tumor infiltrating lymphocytes in combination with systemic inflammatory markers in colon cancer. Clin. Res. Hepatol. Gastroenterol. 47, 102171 (2023).","journal-title":"Clin. Res. Hepatol. Gastroenterol."},{"key":"1192_CR7","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/142425","volume":"2014","author":"D Bugada","year":"2014","unstructured":"Bugada, D., Allegri, M., Lavand\u2019homme, P., De Kock, M. & Fanelli, G. Inflammation-based scores: a new method for patient-targeted strategies and improved perioperative outcome in cancer patients. Biomed. Res. Int. 2014, 142425 (2014).","journal-title":"Biomed. Res. Int."},{"key":"1192_CR8","doi-asserted-by":"publisher","first-page":"e3796","DOI":"10.1210\/clinem\/dgab238","volume":"106","author":"P Marques","year":"2021","unstructured":"Marques, P. et al. Serum Inflammation-based Scores in Endocrine Tumors. J. Clin. Endocrinol. Metab. 106, e3796\u2013e3819 (2021).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"1192_CR9","doi-asserted-by":"publisher","first-page":"795","DOI":"10.2147\/CLEP.S415171","volume":"15","author":"T Gwenzi","year":"2023","unstructured":"Gwenzi, T. et al. Prognostic value of post-operative C-reactive protein-based inflammatory biomarkers in colorectal cancer patients: systematic review and meta-analysis. Clin. Epidemiol. 15, 795\u2013809 (2023).","journal-title":"Clin. Epidemiol."},{"key":"1192_CR10","doi-asserted-by":"publisher","first-page":"1960","DOI":"10.1126\/science.1129139","volume":"313","author":"J Galon","year":"2006","unstructured":"Galon, J. et al. Type, density, and location of immune cells within human colorectal tumors predict clinical outcome. Science 313, 1960\u20131964 (2006).","journal-title":"Science"},{"key":"1192_CR11","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1002\/path.4287","volume":"232","author":"J Galon","year":"2014","unstructured":"Galon, J. et al. Towards the introduction of the \u2018immunoscore\u2019 in the classification of malignant tumours. J. Pathol. 232, 199\u2013209 (2014).","journal-title":"J. Pathol."},{"key":"1192_CR12","doi-asserted-by":"publisher","first-page":"2128","DOI":"10.1016\/S0140-6736(18)30789-X","volume":"391","author":"F Pag\u00e8s","year":"2018","unstructured":"Pag\u00e8s, F. et al. International validation of the consensus Immunoscore for the classification of colon cancer: a prognostic and accuracy study. Lancet 391, 2128\u20132139 (2018).","journal-title":"Lancet"},{"key":"1192_CR13","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1016\/j.immuni.2016.02.025","volume":"44","author":"B Mlecnik","year":"2016","unstructured":"Mlecnik, B. et al. Integrative analyses of colorectal cancer show immunoscore is a stronger predictor of patient survival than microsatellite instability. Immunity 44, 698\u2013711 (2016).","journal-title":"Immunity"},{"key":"1192_CR14","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1002\/cjp2.304","volume":"9","author":"E Alwers","year":"2023","unstructured":"Alwers, E. et al. Validation of the prognostic value of CD3 and CD8 cell densities analogous to the Immunoscore\u00ae by stage and location of colorectal cancer: an independent patient cohort study. J. Pathol. Clin. Res. 9, 129\u2013136 (2023).","journal-title":"J. Pathol. Clin. Res."},{"key":"1192_CR15","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.595835","volume":"11","author":"PC Hart","year":"2020","unstructured":"Hart, P. C., Rajab, I. M., Alebraheem, M. & Potempa, L. A. C-Reactive Protein and Cancer-Diagnostic and Therapeutic Insights. Front Immunol. 11, 595835 (2020).","journal-title":"Front Immunol."},{"key":"1192_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/j.esmoop.2024.102982","volume":"9","author":"T Gwenzi","year":"2024","unstructured":"Gwenzi, T. et al. Post-operative C-reactive protein as a strong independent predictor of long-term colorectal cancer outcomes: consistent findings from two large patient cohorts. ESMO Open 9, 102982 (2024).","journal-title":"ESMO Open"},{"key":"1192_CR17","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1016\/S2468-1253(24)00091-8","volume":"9","author":"D Wankhede","year":"2024","unstructured":"Wankhede, D. et al. Clinical significance of combined tumour-infiltrating lymphocytes and microsatellite instability status in colorectal cancer: a systematic review and network meta-analysis. Lancet Gastroenterol. Hepatol. 9, 609\u2013619 (2024).","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"1192_CR18","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1007\/s00384-024-04766-w","volume":"39","author":"A Gerdin","year":"2024","unstructured":"Gerdin, A. et al. Anastomotic leakage after resection for rectal cancer and recurrence-free survival in relation to postoperative C-reactive protein levels. Int J. Colorectal Dis. 39, 193 (2024).","journal-title":"Int J. Colorectal Dis."},{"key":"1192_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.patter.2023.100736","volume":"4","author":"J Kong","year":"2023","unstructured":"Kong, J. et al. Information about immune cell proportions and tumor stage improves the prediction of recurrence in patients with colorectal cancer. Patterns 4, 100736 (2023).","journal-title":"Patterns"},{"key":"1192_CR20","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1158\/1078-0432.CCR-18-1851","volume":"26","author":"HK Angell","year":"2020","unstructured":"Angell, H. K., Bruni, D., Barrett, J. C., Herbst, R. & Galon, J. The Immunoscore: Colon Cancer and Beyond. Clin. Cancer Res. 26, 332\u2013339 (2020).","journal-title":"Clin. Cancer Res."},{"key":"1192_CR21","doi-asserted-by":"crossref","unstructured":"Marliot, F. et al. Analytical validation of the immunoscore and its associated prognostic value in patients with colon cancer. J. Immunother Cancer. 8, e000272 (2020).","DOI":"10.1136\/jitc-2019-000272"},{"key":"1192_CR22","unstructured":"Mlecnik, B. et al. Multicenter international study of the consensus immunoscore for the prediction of relapse and survival in early-stage colon cancer. Cancers (Basel). 15, 418 (2023)."},{"key":"1192_CR23","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1016\/j.semcancer.2022.01.006","volume":"86","author":"X Cheng","year":"2022","unstructured":"Cheng, X., Zhang, H., Hamad, A., Huang, H. & Tsung, A. Surgery-mediated tumor-promoting effects on the immune microenvironment. Semin Cancer Biol. 86, 408\u2013419 (2022).","journal-title":"Semin Cancer Biol."},{"key":"1192_CR24","doi-asserted-by":"crossref","unstructured":"Bower, J. E. et al. Acute and chronic effects of adjuvant therapy on inflammatory markers in breast cancer patients. JNCI Cancer Spectr 6, pkac052 (2022)","DOI":"10.1093\/jncics\/pkac052"},{"key":"1192_CR25","doi-asserted-by":"crossref","unstructured":"Walker, A. K., Chan, R. J., Vardy, J. L. Sustained mild inflammation in cancer survivors: where to from here? JNCI Cancer Spectr. 6, pkac054 (2022).","DOI":"10.1093\/jncics\/pkac054"},{"key":"1192_CR26","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1016\/j.ccell.2015.10.012","volume":"28","author":"L Galluzzi","year":"2015","unstructured":"Galluzzi, L., Buqu\u00e9, A., Kepp, O., Zitvogel, L. & Kroemer, G. Immunological effects of conventional chemotherapy and targeted anticancer agents. Cancer Cell 28, 690\u2013714 (2015).","journal-title":"Cancer Cell"},{"key":"1192_CR27","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1245\/s10434-016-5659-4","volume":"24","author":"DG Watt","year":"2017","unstructured":"Watt, D. G., McSorley, S. T., Park, J. H., Horgan, P. G. & McMillan, D. C. A Postoperative systemic inflammation score predicts short- and long-term outcomes in patients undergoing surgery for colorectal cancer. Ann. Surg. Oncol. 24, 1100\u20131109 (2017).","journal-title":"Ann. Surg. Oncol."},{"key":"1192_CR28","doi-asserted-by":"publisher","first-page":"1593","DOI":"10.21873\/anticanres.14920","volume":"41","author":"M Shibutani","year":"2021","unstructured":"Shibutani, M. et al. A high postoperative serum c-reactive protein level has a negative impact on long-term survival, regardless of postoperative infectious complications, in patients who undergo laparoscopic surgery for colorectal cancer. Anticancer Res. 41, 1593\u20131598 (2021).","journal-title":"Anticancer Res."},{"key":"1192_CR29","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1007\/s10654-017-0298-z","volume":"32","author":"H Maalmi","year":"2017","unstructured":"Maalmi, H. et al. Relationship of very low serum 25-hydroxyvitamin D(3) levels with long-term survival in a large cohort of colorectal cancer patients from Germany. Eur. J. Epidemiol. 32, 961\u2013971 (2017).","journal-title":"Eur. J. Epidemiol."},{"key":"1192_CR30","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-17204-5","volume":"7","author":"P Bankhead","year":"2017","unstructured":"Bankhead, P. et al. QuPath: Open source software for digital pathology image analysis. Sci. Rep. 7, 16878 (2017).","journal-title":"Sci. Rep."}],"container-title":["npj Precision Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41698-025-01192-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41698-025-01192-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41698-025-01192-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,28]],"date-time":"2025-11-28T17:02:18Z","timestamp":1764349338000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41698-025-01192-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,25]]},"references-count":30,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1192"],"URL":"https:\/\/doi.org\/10.1038\/s41698-025-01192-1","relation":{},"ISSN":["2397-768X"],"issn-type":[{"value":"2397-768X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,25]]},"assertion":[{"value":"4 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"386"}}